Literature DB >> 11549669

Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase.

A Fisher1, E C Friel, R Bernhardt, C Gomez-Sanchez, J M Connell, R Fraser, E Davies.   

Abstract

In glucocorticoid-suppressible hyperaldosteronism, 11beta- hydroxylase activity is impaired. A chimeric enzyme formed from the control elements of 11beta-hydroxylase and the structural elements of aldosterone synthase is expressed ectopically in the zona fasciculata, thus exposing cortisol to aldosterone synthase. Increased quantities of 18-hydroxycortisol and 18-oxocortisol are synthesized, which, it has been suggested, might have a local inhibitory effect on the normal 11beta-hydroxylase. The effects of these compounds and also of 18-hydroxydeoxycorticosterone were tested in cells stably transfected with CYP11B1 and CYP11B2, the genes encoding 11beta-hydroxylase and aldosterone synthase, respectively. Neither 18-hydroxycortisol nor 18-oxocortisol affected the efficiency of use of 11-deoxycorticosterone or 11-deoxycortisol as substrates by the enzymes. 18-Hydroxydeoxycorticosterone significantly reduced the conversion rate of 11-deoxycorticosterone to corticosterone and that of 11-deoxycortisol to cortisol by both enzymes, but the production rate of 18- hydroxycorticosterone and aldosterone by aldosterone synthase increased. Aldosterone synthase was able to convert 18-hydroxydeoxycorticosterone to 18-hydroxycorticosterone and aldosterone, although its affinity for this substrate was lower (4.76 micromol/liter) than that for 11-deoxycorticosterone (0.11 micromol/liter). 11beta-Hydroxylase was unable to convert 18- hydroxydeoxycorticosterone to 18-hydroxycorticosterone. 18-Hydroxycortisol and 18-oxocortisol are not, therefore, the cause of lower 11beta-hydroxylase activity in glucocorticoid- suppressible hyperaldosteronism. 18-Hydroxydeoxycorticosterone can be converted to aldosterone, but its local concentration in man and its K(m) suggest that it is unlikely to be important.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549669     DOI: 10.1210/jcem.86.9.7797

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism.

Authors:  Yasuhiro Nakamura; Fumitoshi Satoh; Ryo Morimoto; Masataka Kudo; Kei Takase; Celso E Gomez-Sanchez; Seijiro Honma; Mitsunobu Okuyama; Kouwa Yamashita; William E Rainey; Hironobu Sasano; Sadayoshi Ito
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

3.  Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics.

Authors:  Luc Roumen; Marijn P A Sanders; Koen Pieterse; Peter A J Hilbers; Ralf Plate; Erica Custers; Marcel de Gooyer; Jos F M Smits; Ilona Beugels; Judith Emmen; Harry C J Ottenheijm; Dirk Leysen; J J R Hermans
Journal:  J Comput Aided Mol Des       Date:  2007-07-24       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.